iCAD to Report Fourth Quarter and Fiscal Year Ended December 31 2018 Financial Results on Monday March 18

iCAD to Report Fourth Quarter and Fiscal Year Ended December 31, 2018 Financial Results on Monday, March 18

17:09 EDT 13 Mar 2019 | Biotech 365

NASHUA, N.H., March 13, 2019 (GLOBE NEWSWIRE) — iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the fourth quarter and fiscal year ended December … Continue reading →

More From BioPortfolio on "iCAD to Report Fourth Quarter and Fiscal Year Ended December 31, 2018 Financial Results on Monday, March 18"